Justpoint

Justpoint uses proprietary artificial intelligence to analyze billions of medical records and scientific reports to proactively identify pharmaceuticals and consumer products that may be causing harm before regulatory bodies do. When potential dangers are confirmed through retrospective epidemiological studies, the company works with its legal arm or partners to initiate litigation against responsible parties. Early results include processing over 1,000 claims daily and helping victims recover an average of $355K per settlement. The technology flagged dangers in Oxbryta nearly two years before its withdrawal from the market. The company’s findings are supplied to law firms such as Justpoint PLLC which then pursue class action or mass tort lawsuits. No clinical trial results—focuses on public health impact via litigation.